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Summary
Objective: One of the recognized candidate genes of osteoarthritis (OA) is the ADAM metallopeptidase domain 12 (meltrin alpha) gene. We
investigated the potential role of two single nucleotide polymorphisms (SNP) of the ADAM12 gene in susceptibility to radiographic knee OA
and its progression in an Estonian cohort.
Methods: The rs3740199 and rs1871054 polymorphisms were genotyped according to restriction fragment polymorphism in a population-
based cohort consisting of 189 subjects selected from the age group 32e55 years. The radiological features of OA were measured in the
tibio- and patellofemoral joints (PFJ). The X-ray investigation was repeated 3 years later for estimation of OA progression.
Results: We found statistically signiﬁcant association between rs3740199 polymorphism and patellofemoral OA in male patients (P¼ 0.014),
genetic risk was mostly related to CC homozygosity. The same SNP also affected the presence of advanced grade (IIþ III) osteophytes in the
whole group (P¼ 0.042) and the occurrence of osteophytes on the patellar margins in the PFJ (P¼ 0.046). In OA progression the most sig-
niﬁcant association was found between joint space narrowing of the tibiofemoral joint and rs3740199 SNP in women (P¼ 0.018). The
rs1871054 polymorphism was not related to OA susceptibility or to progression traits. In our study the haplotype GC (rs3740199/
rs1871054) was associated with reduced risk for development of osteophytes in the PFJ (P¼ 0.041).
Conclusions: We conclude that rs3740199 polymorphism may affect occurrence of knee OA and its progression. We also hypothesize that the
genetic contribution of ADAM12 to OA is remarkably gender-dependent and anatomical site-speciﬁc.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is the most common arthritic disorder
and a leading cause of musculoskeletal disability in devel-
oped countries1. In addition to age, sex, body weight and
trauma, the genetic background also contributes to the
risk of OA. A classical twin study estimated the heritability
of knee and hip OA to be 39e65% in affected women2.
The genetic background seems to be less important in
men3.
In OA the knee is the most signiﬁcant clinically affected
site4. Owing the tri-compartmental anatomical structure of
the knee joint (medial and lateral tibiofemoral joint (TFJ),
and patellofemoral joint (PFJ)), numerous radiographic pat-
terns of knee OA are possible. Traditionally, knee OA has
been regarded as a disorder of the TFJ. Recently, increas-
ingly more attention has been given to the importance of pa-
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1093the opinion of some authors patellofemoral OA should be
considered a distinct entity6. Epidemiological studies sug-
gest that the risk factors associated with the disease are dif-
ferent for patellofemoral OA and tibiofemoral OA7,8. At
present it is authentically unknown if the genetic risk factors
contributing to development of OA in TFJ and PFJ are dif-
ferent as well. However, a recent thorough British study in-
vestigating the risk of tibio- and patellofemoral OA in
siblings reported a relative risk of 2.9 (95 % CI 2.3e3.7)
for tibiofemoral OA and 1.7 (95 %CI 1.4e2.2) for patellofe-
moral OA after adjusting for environmental factors9.
In fact, since 2002 the genetic pattern of OA has been in-
vestigated by genome-wide linkage analysis and numerous
association studies of candidate genes have been per-
formed with a total number of more than 50 genes10. The
most convincing evidence for involvement in OA has been
noted for the interleukin 1 (IL1) gene cluster, the matrilin 3
gene (MATN3), the IL-4 receptor a chain gene, the secreted
frizzled related protein 3 gene (FRZB), the asporine gene
and the metalloproteinase gene ADAM1211. The associa-
tion between OA and the ADAM12 gene has probably
been the least studied12,13. This gene encodes a member
of the disintegrin and metalloprotease protein family. The
members of this family are implicated in a variety of
1094 I. Kerna et al.: ADAM12 gene SNP’s in early knee OAbiological processes involving cellecell and cellematrix
interactions in fertilization, muscle development and
neurogenesis14.
The aim of the present pilot study was to investigate the
potential role of two single nucleotide polymorphisms
(SNPs), the rs3740199 and rs1871054, of the ADAM12
gene in susceptibility to radiological knee OA and its pro-
gression in an Estonian cohort aged 32e55 years.Patients and methodsSUBJECTSThe primary survey was conducted in a small South-Estonian town of
Elva in 2002. A questionnaire on knee problems was sent to all 559 subjects
aged 32e55 years (family doctor’s list) and a total of 348 responses were ob-
tained. Of all contacted subjects 190 (118 women, 82 men) participated in an
in-depth examination (X-ray and ultrasonography of both knee joints, func-
tional knee tests). The radiograph of one participant was considered unsuit-
able and he was excluded from ﬁnal analysis. Blood samples were collected
for assessment of bone and cartilage turnover markers15 and all subjects
were subjected to genetical investigation.
Standardised weight-bearing antero-posterior radiographs of TFJ and ax-
ial radiographs of the knee joint with PFJ in 60 ﬂexion were used for radio-
graphic assessment of knee OA16. The two main features of knee OA,
presence of joint space narrowing (JSN) and osteophyte development,
were estimated independently by two radiologists in both TFJ and PFJ ac-
cording to the grading system (grades 0eIII) of Nagaosa et al.17. The highest
grade was regarded as the stage of OA in the corresponding joint. The high-
est grade of OA in TFJ or PFJ was regarded as the global stage of knee OA
and the highest grade of osteophytes in TFJ or PFJ was regarded as the
global grade of osteophytes.
To estimate the progression of knee OA, a similar follow-up study was
performed 3 years later with a total number of 141 participants (98 women).
Progression was deﬁned as a change in the stage of JSN and grade of
osteophytes with or without a change in the global grade of knee OA.
The radiographs of the participants from the primary study who showed
a reduction from higher radiographic knee OA grade at baseline to lower
grade at follow-up (N¼ 10) were reassessed. The ﬁnal decision about the
knee OA grade at baseline and at follow-up was made by consensus be-
tween the same radiologists.
The study was approved by the Ethics Committee of the University of
Tartu and informed consent was obtained from all subjects.GENOTYPINGGenomic DNA was puriﬁed from the samples of peripheral venous blood
by salt extraction.
The polymorphisms of the ADAM12 gene (rs3740199 and rs1871054)
were ampliﬁed by polymerase chain reaction (PCR) and analyzed by restric-
tion fragment polymorphism (RFLP). The forward primer (50 GCT GAT GAA
GTT GTC AGA GCC T 30) and the reverse primer (50 GGA TCC CTC ATC
AGC ACT GTC AC 30) were used for ampliﬁcation of rs3740199 (48
C>G). The size of the fragments of the PCR products after restriction
with PpiI (Fermentas) was 231 bp for theC-allele (Arginine) and 265 bp for
the G-allele (Glycine).
The rs1871054 (C> T) were ampliﬁed with the forward primer (50 TCT
GCT TTG ACA GTG TGC ATG GCT 30) and the reverse primer (50 GCT
CTC CAG AGT AGC ACA GGT CAC 30). Eco 91I (Fermentas) was used
for RFLP and the ﬁnal product size was 131 bp for the C allele and 150 bp
for the T allele.
The PCR program consisted of the following steps. The ﬁrst step was ini-
tial denaturation in which the reaction was incubated for 4 min at 95C. In the
second step, DNA was ampliﬁed for 37 cycles of denaturation at 95C for
1 min, annealing at 60C (rs3740199) and at 62C (rs1871054) for 3 min,
and extension at 72C for 60 s.STATISTICAL ANALYSISThe association between the SNPs and different radiographic features of
knee OA was evaluated by the chi-square test and by logistic or linear re-
gression models in the R environment ver. 2.4.0 (The R Foundation for Sta-
tistical Computing, Boston, MA)18. The haplo.stats (haplo.glm) package in
the R-program was used to estimate the haplotypes and the associations
of the investigated SNPs. The Hardy-Weinberg equilibrium (HWE) was eval-
uated by the genetics package (HWE.test). The age and the body mass
index (BMI) of the subjects were used as the covariates in most statistical
calculations.ResultRADIOLOGICAL KNEE OA GRADES AND ALLELIC
DISTRIBUTION OF SNPsOn examination, 118 (87 women and 31 men) of
the189 participants were diagnosed with different stages
(IeIII) of knee OA. Seventy-one subjects (52 women
and 19 men) without radiological features of knee OA
were classiﬁed as the control group. The subjects with
stage I knee OA formed the largest group (49% of all par-
ticipants). Advanced radiological features of knee OA
(grades IIþ III) were found in 25 patients. Twenty-one
of the 118 patients with features of radiological knee
OA reported absence of knee pain or other knee
problems.
The frequencies (%) of SNPs genotypes for the study
groups are presented in Table I. All genotypes of both
SNPs were found to be in HWE.
The calculated allelic frequency in rs3740199 SNP was
30% for the G-allele and 70% for the C allele. For
s1871054 polymorphism the following distribution was ob-
tained: 49.5% and 50.5% for the C and T alleles, respec-
tively. The estimated distribution of SNP’s genotypes
according to two main features of OA is shown in Table II.
None of the estimated haplotypes (rs3740199/rs1871054)
had a frequency lower than 5% (Table III).CONSEQUENCE OF GENETIC ASSOCIATION FOR
RADIOGRAPHIC KNEE OA SUSCEPTIBILITY TRAITSIn order to investigate possible association between the
genotyped ADAM12 SNPs and radiological knee OA, the
rs3740199 and rs1871054 alleles were collated to (1) global
grade of knee OA and global grade of osteophytes, (2)
grade of OA and two main features of OA (osteophytes,
JSN) in TFJ and PFJ.
We found signiﬁcant association between rs3740199
polymorphism and patellofemoral OA in male patients (OR
3.55, P¼ 0.014)(Table IV), while CC homozygotes showed
the highest risk compared with the other genotypes. No
such association was found in the group of women. A de-
tailed investigation of osteophytes in both joints revealed
that rs3740199 is linked to the presence of advanced grade
(IIþ III) osteophytes in the whole group (P¼ 0.042). Com-
parison of the occurrence of osteophytes separately at dif-
ferent sites of TFJ and PFJ revealed association between
rs3740199 and presence of osteophytes in PFJ, particularly
on the lateral patellar margins (surface) in affected subjects
(P¼ 0.046).
We did not ﬁnd statistically signiﬁcant association
between rs3740199 SNP and the other investigated radio-
logical parameters.
No association was found between any of the tested
parameters and rs1871054 SNP.Haplotype analysis
We found that the GC haplotype was associated with
decreased risk of radiographical OA in PFJ in men (Table
IV). The same haplotype was also associated with reduced
risk for development of osteophytes in PFJ in the whole
group (OR¼ 0.24, P¼ 0.041). Most likely, the trend of
the protective effect of the haplotype regarding osteo-
phytes was present in women (P¼ 0.058). No association
was observed between the other haplotypes and any traits
of knee OA.
Table I
Study groups and distribution of ADAM12 gene genotypes in subjects with and without radiographical knee OA in Estonian cohort at baseline
(2002)
ADAM12 gene Tibiofemoral knee OA (TFOA) Patellofemoral knee OA (PFOA)
Subjects without Subjects with OR (95% CI) P-value Subjects without Subjects with OR (95% CI) P-value
rs3740199 genotypes
CC
Whole group 65 (53%) 28 (42%) 0.85 (0.29e2.49) 0.76 41 (44%) 53 (55%) 1.01 (0.37e2.80) 0.97
Male 16 (46%) 6 (40%) 0.71 (0.1e4.89) 0.72 7 (28%) 16 (64%) 10.7 (1.05e109.8) 0.045
Female 49 (56%) 22 (43%) 0.9 (0.24e3.30) 0.82 34 (51%) 37 (51%) 0.36 (0.09e1.45) 0.15
CG
Whole group 46 (37%) 32 (49%) 1.39 (0.47e4.09) 0.55 43 (47%) 34 (35%) 0.65 (0.23e1.83) 0.42
Male 15 (43%) 7 (47%) 0.93 (0.14e6.37) 0.94 13 (52%) 8 (32%) 3.46 (0.34e34.8) 0.29
Female 31 (35%) 25 (49%) 1.61 (0.43e5.98) 0.48 30 (45%) 26 (36%) 0.29 (0.07e1.18) 0.08
GG
Whole group 12 (10%) 6 (9%) 1* 8 (9%) 10 (10%) 1*
Male 4 (11%) 2 (13%) 1* 5 (20%) 1 (4%) 1*
Female 8 (9%) 4 (27%) 1* 3 (4%) 9 (13%) 1*
G-allele %y
Whole group 28.5 33.3 0.78 (0.23e1.94) 0.37 32.1 27.8 0.86 (0.55e1.33) 0.50
Male 32.9 36.6 1.18 (0.48e2.89) 0.71 46 20 0.33 (0.14e0.79) 0.013
Female 26.7 32.4 1.28 (0.75e2.17) 0.37 26.9 30.5 1.24 (0.74e2.08) 0.42
rs1871054 genotypes
TT
Whole group 30 (24%) 18 (27%) 1.24 (0.53e2.9) 0.61 24 (26%) 24 (25%) 0.7 (0.31e1.59) 0.39
Male 10 (28%) 4 (27%) 1.07 (0.18e6.21) 0.94 7 (28%) 7 (28%) 0.57 (0.11e2.87) 0.49
Female 20 (23%) 14 (27%) 1.34 (0.51e3.56) 0.55 17 (25%) 17 (23%) 0.75 (0.29e1.94) 0.55
CT
Whole group 62 (51%) 33 (50%) 1.08 (0.51e2.28) 0.84 49 (54%) 46 (47%) 0.66 (0.32e1.35) 0.25
Male 17 (49%) 8 (53%) 1.19 (0.25e5.68) 0.83 14 (56%) 11 (44%) 0.45 (0.10e1.93) 0.28
Female 45 (51%) 25 (49%) 1.06 (0.45e2.50) 0.88 35 (52%) 35 (49%) 0.75 (0.33e1.70) 0.49
CC
Whole group 31 (25%) 15 (23%) 1* 19 (20%) 27 (28%) 1*
Male 8 (23%) 3 (20%) 1* 4 (16%) 7 (28%) 1*
Female 23 (26%) 12 (24%) 1* 15 (23%) 20 (28%) 1*
C allele %y
Whole group 50.4 47.7 0.9 (0.59e1.37) 0.62 47.2 51.5 1.19 (0.79e1.78) 0.41
Male 47.1 46.6 0.98 (0.42e2.31) 0.97 44 50 1.27 (0.58e2.80) 0.55
Female 51.7 48 0.86 (0.53e1.41) 0.56 48.5 52.1 1.15 (0.72e1.85) 0.55
*Reference.
yMinor allele.
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features
The prevalence of radiographic knee OA in the study co-
hort was 62% at baseline and 86% after 3 years of follow-up.
The most signiﬁcant association was found between
rs3740199 and progression of OA assessed on the basis
of JSN of TFJ in women (OR 2.66, 95% CI 1.19e5.98,
P¼ 0.018). The observed summary progression (osteophy-
tesþ JSN in TFJ) of tibiofemoral OA in female patients was
also associated with the same SNP (OR 1.96, 95% CI
1.00e3.84, P¼ 0.048). However, after adjusting for age
and BMI, the association lost statistical signiﬁcance
(P¼ 0.064). No signiﬁcant association was observed be-
tween rs3740199 SNP and progression of OA in men.
The rs1871054 SNP was not related to any traits of OA
progression.
Discussion
In the present study we evaluated the association be-
tween ADAM12, a recently discovered OA candidategene, and presence and progression traits of knee OA in
a younger to middle-aged general population (32e55
years). Two SNPs of the gene were investigated. The ﬁrst,
rs3740199 (G>C) in the second exon, represents mis-
sense polymorphism leading to substitution of Gly48Arg.
The rs1871054 (C> T) is located in the eleventh intron.
The distribution of the alleles of rs1871054 SNP (49.5% C
and 50.5% T) in the Estonian cohort was similar to that in
the HapMap European population19. The number of the an-
cestral G-allele carriers of rs3740199 SNP, on the contrary,
was signiﬁcantly lower in the studied population compared
to the Caucasians reported by HapMap (30% vs 61%).
However, our ﬁnding is similar to that found in a recently
published British Chingford Study where the G-allele of
rs3740199 was observed as a minor allele12.
Preliminary data about the possible role of the ADAM12
gene in knee OA was recently published by Valdes et al.
(2004). The ADAM12 was selected alongside with other
genes of interest, expressed differently in the healthy and
in OA cartilage and synovium, as the potential affector
gene implicated in knee OA pathogenesis12. This investiga-
tion, based on a Chingford Study cohort, UK (women aged
Table II
Distribution of ADAM12 gene genotypes in subjects with and without knee OA radiological features in Estonian cohort at baseline (2002)
ADAM12 gene Osteophytes (OPH) JSN
Subjects without Subjects with OR (95% CI) P-value Subjects without Subjects with OR (95% CI) P-value
rs3740199 genotypes
CC
Whole group 62 (50%) 31 (48%) 1.00 (0.34e2.92) 1.00 48 (49%) 45 (50%) 0.94 (0.34e2.57) 0.90
Male 14 (42%) 8 (47%) 1.14 (0.17e7.69) 0.89 10 (37%) 12 (52%) 6.00 (0.60e60.2) 0.13
Female 48 (58%) 23 (48%) 0.96 (0.26e3.51) 0.94 38 (53%) 33 (48%) 0.43 (0.12e1.57) 0.20
CG
Whole group 50 (40%) 28 (43%) 1.12 (0.38e3.31) 0.83 41 (43%) 37 (40%) 0.90 (0.32e2.52) 0.84
Male 15 (46%) 7 (41%) 0.93 (0.14e6.37) 0.94 12 (44%) 10 (44%) 4.17 (0.42e41.8) 0.22
Female 35 (38%) 21 (44%) 1.20 (0.32e4.48) 0.77 29 (41%) 27 (40%) 0.47 (0.13e1.72) 0.25
GG
Whole group 12 (10%) 6 (9%) 1* 9 (9%) 9 (10%) 1*
Male 4 (12%) 2 (12%) 1* 5 (19%) 1 (4%) 1*
Female 8 (9%) 4 (8%) 1* 4 (6%) 8 (12%) 1*
G-allele %y
Whole group 29.8 30.8 1.03 (0.65e1.62) 0.92 30.1 30.2 1.03 (0.67e1.60) 0.89
Male 34.8 32.4 0.89 (0.37e2.15) 0.80 40.7 26.1 0.51 (0.22e1.20) 0.13
Female 28 30.2 1.08 (0.63e1.86) 0.78 26.1 31.6 1.36 (0.81e2.28) 0.25
rs1871054 genotypes
TT
Whole group 28 (23%) 20 (31%) 3.43 (0.64e3.43) 0.36 23 (24%) 25 (27%) 1.19 (0.58e2.66) 0.68
Male 9 (27%) 5 (29%) 1.48 (0.27e8.27) 0.66 8 (29%) 6 (26%) 0.63 (1.13e3.07) 0.56
Female 19 (21%) 15 (31%) 1.51 (0.57e4.00) 0.40 15 (21%) 19 (28%) 1.50 (0.55e3.83) 0.39
CT
Whole group 65 (52%) 30 (46%) 0.95 (0.45e2.03) 0.89 51 (52%) 44 (49%) 0.94 (0.46e1.91) 0.87
Male 16 (49%) 9 (53%) 1.50 (0.32e7.12) 0.61 14 (52%) 11 (48%) 0.65 (0.16-2.72) 0.56
Female 49 (54%) 21 (44%) 0.82 (0.35e1.95) 0.66 37 (52%) 33 (48%) 1.06 (0.47e2.39) 0.89
CC
Whole group 31 (25%) 15 (23%) 1* 24 (24%) 22 (24%) 1*
Male 8 (24%) 3 (18%) 1* 5 (19%) 6 (26%) 1*
Female 23 (25%) 12 (25%) 1* 19 (27%) 16 (24%) 1*
C alleley%
Whole group 51.2 46.2 0.82 (0.53e1.25) 0.35 50.5 48.3 0.92 (0.61e1.37) 0.67
Male 48.5 44.1 0.84 (0.37e1.93) 0.68 44.4 50 1.25 (0.57e2.75) 0.58
Female 52.2 46.9 0.81 (0.49e1.33) 0.40 52.8 47.8 0.82 (0.51e1.31) 0.40
*Reference.
yMinor allele.
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rs3740199 SNP and radiographic knee OA (score >2 by
Kellgren/Lawrence, K/L) or presence of osteophytes in
TFJ. In the present study, we failed to detect association
between the distribution of investigated ADAM12 genotypes
and radiological OA in TFJ (assessed by the radiographic
Atlas of Knee OA16) in whole population or separately in
men and women. We believe that the absence of associa-
tion in our study can be explained by gender and age-re-
lated differences between the investigated cohorts. The
study group consisted of female and male subjects, and
the age of the participants (strongly restricted to the range
32e55 years) was younger compared with the Chingford
Study. In addition, despite the fact that the K/L score >2
is comparable to the OA score >1 used in our study,
some discrepancies could have resulted from the methodol-
ogy of assessment of OA.
The PFJ compartment is frequently afﬂicted by the dis-
ease process and PFJ OA is associated with considerable
pain and disability4. The patella demonstrates more severe
degeneration earlier in the disease process compared with
the juxtaposed femoral groove20. The present study is the
ﬁrst, to the best of our knowledge, to investigate thepotential relationship between the ADAM12 gene and pres-
ence of patellofemoral OA. In this study rs3740199 SNP
was associated with susceptibility to patellofemoral OA in
male patients and the CC genotype of rs3740199 carried
the highest risk in comparison with the other genotypes.
The reliability and importance of this ﬁnding should be val-
idated in further research.
Evaluation of the genetic background of not only the total
score of OA but also of different processes and locations of
OA was one of main tasks of our study. Analysis of the fea-
tures of regenerative response of the cartilage through de-
velopment of osteophytes revealed relationship between
presence of advanced stage osteophytes in both joints
(TFJþPFJ) and rs3740199. In the cohort of the above
mentioned Chingford Study rs3740199 SNP was signiﬁ-
cantly associated with presence of osteophytes12. Despite
the circumstance that in our study the association of the
gene was only revealed in the presence of the advanced
stages of osteophytes (II and III), we believe that this ﬁnding
is in concert with the data described ﬁrst by Valdes et al.12.
Analysis of different locations of OA related changes in PFJ
demonstrated that rs3740199 polymorphisms are mainly
associated with bone spurs on the lateral patellar margins.
Table III
The rs3740199/rs1871054 haplotype frequencies and associations














Whole group 33.9 37.5 1*
Male 28.3 40.3 1*
Female 35.2 36.4 1*
CT
Whole group 37.2 31.5 0.42 (0.74e4.28)
Male 32.3 29.1 0.53 (0.13e2.08)
Female 40.3 32.8 0.77 (0.41e1.48)
GC
Whole group 16.1 11.6 0.59 (0.24e1.42)
Male 16.4 8.1 0.23 (0.03e1.86)
Female 15.8 13 0.68 (0.25e1.79)
GT
Whole group 12.8 19.4 1.43 (0.70e2.92)
Male 23 22,5 0.68 (0.21e2.14)
Female 8.7 17.8 2.34 (0.83e6.65)
*Reference.
1097Osteoarthritis and Cartilage Vol. 17, No. 8No signiﬁcant inﬂuence of rs3740199 was seen on the deg-
radation of the cartilage tissue measured as JSN in both
joints.
Another SNP investigated by us, rs1871054, showed no
association with any OA susceptibility traits in the Estonian
population. This ﬁnding differs from the data of Valdes and
co-workers21 who included the rs1871054 in theTable IV
The rs3740199 SNP and rs3740199/rs1871054 (GC) haplotype as-
sociations with radiographic knee OA susceptibility features
OR (95% CI) P-value
rs3740199, investigated trait
Presence of PFOA*
Whole group 1.25 (0.80e1.94) 0.328
Male patients 3.55 (1.29e9.76) 0.014
Female patients 0.89 (0.53e1.52) 0.679
Presence of OPH (advanced stage IIþ III)*
Whole group 19.7 (1.12e345.00) 0.042
Male patientsy e e
Female patients 22.91 (0.79e663.98) 0.068
Presence of POPH*
Whole group 2.77 (1.02e7.53) 0.046
Male patients 7.04 (0.82e60.71) 0.076
Female patients 1.92 (0.59e6.23) 0.277
rs3740199/rs1871054 GC, investigated trait
Presence of PFOPH
Whole group 0.24 (0.06e0.94) 0.041
Male patients 0.30 (0.02e4.10) 0.368
Female patients 0.20 (0.04e1.06) 0.058
Presence of PFOA
Whole group 0.55 (0.24e1.32) 0.183
Male patients 0.10 (0.01e0.95) 0.046
Female patients 0.77 (0.30e1.99) 0.592
PFOA - OA of patellofemoral joint, OPH - osteophytes, POPH -
osteophytes on patellar margins, PFOPH - osteophytes in PF joint.
*Data is adjusted for age and BMI.
yGroup is too small for analysis.mathematical model of the additive effect of individual
genes in predicting the risk of knee OA. However, further
studies on larger material are needed to validate the asso-
ciation between rs1871054 and knee OA development.
The effect of each SNP often appears in presence of
other alleles in certain haplotype combinations. In the pres-
ent study, the analysis of the haplotypes of ADAM12
showed that the GC haplotype (rs3740199/rs1871054)
has a signiﬁcant protective effect by reducing the risk for de-
velopment of patellofemoral osteophytes. No such associa-
tion was seen for the GT haplotype. This observation
suggests that rs1871054 modulates the protective effect
of rs3740199 polymorphism. The protective effect of sev-
eral haplotypes of four ADAM12 SNPs in relation to knee
OA in a British population was reported earlier13, although
no one of the separately investigated SNPs was signiﬁ-
cantly associated with knee OA.
Progression of OA is also inﬂuenced by the genetic back-
ground22. Investigation of the 3-year course of knee OA in
the Estonian population showed that rs3740199 SNP was
associated with traits of knee OA progression measured
as a change of JSN in TFJ. This association was signiﬁcant
in women but not in men. However, it is difﬁcult to explain
why rs3740199 SNP carries the risk of patellofemoral OA
for men and seems to determine the progression rate of
OA in TFJ for women. One can suppose that the process
of OA in men and women differs in terms of age at onset
and probably progression rate as well as location of af-
fected joints. The prevalence of knee OA in the investigated
Estonian cohort aged 32e55 years increased up to 24%
during 3-year follow-up. This ﬁgure is much higher than
those reported previously12,23. It should be mentioned that
in other similar studies the mean age of participants at fol-
low-up was over 60 (70) years. One can presume that in-
vestigation of the middle-aged population in the present
study revealed the active development phase of knee OA,
which resulted in the extraordinary high incidence rate.
This observation is in agreement with the suggestion of
the cyclic progression of knee OA24.
The role of the ADAM12 gene and its polymorphisms in
the pathogenesis of OA is not well understood. ADAM12
was recently identiﬁed as one of the four protease genes
signiﬁcantly over-expressed in damaged OA cartilage com-
pared to intact one25. These ﬁndings support the putative
role of the ADAM12 gene in cartillage destruction and OA
development. Some in vitro studies suggest a regulatory
role of ADAM12 in human bone formation and osteoclast
differentiation26. We also found signiﬁcant association be-
tween ADAM12 polymorphisms and presence of osteo-
phytes, which conﬁrms the possible association of this
gene with bone regenerative processes.
ADAM12 is a multifunctional protein, containing pro-,
metalloprotease, disintegrin and cysteine-rich domains e
the components characteristic of the ADAM family. The hu-
man ADAM12 exists in two splice variants: a membrane-
anchored (ADAM12m) and a shorter, secreted form
(ADAM12-S) without transmembrane and cytoplasmatic do-
mains27. Both, the transmembrane and the secreted forms
of ADAM12 are active metalloproteases28.
The ADAM12 protein was found to stimulate longitudinal
bone growth in ADAM12-S transgenic mice by modulating
chondrocyte proliferation and maturation. The metallopro-
tease activity of the protein was needed for that effect29.
The recent data suggest the involving of membrane-
anchored ADAM12 (ADAM-12m) in chondrocyte prolifera-
tion30. The ADAM12m shown to have the proteolytical
activity in relation to insulin-like growth factor binding
1098 I. Kerna et al.: ADAM12 gene SNP’s in early knee OAprotein 5 (IGFBP-5). It leads to enchanced bioavailability of
insulin growth factor -I (IGF-I) from IGF-I-IGFBP-5 complex
resulting in chondrocyte proliferation30.
The main limitation of the present study to be mentioned
is the small number of subjects with advanced stage (IIþ III)
of knee OA. However, in a population-based study of pre-
dominantly middle-aged persons this is quite expected. In
addition, several environmental risk factors (e.g., selected
physical activity) contributing to knee OA were not taken
into consideration. More detailed characterization of the pa-
tients’ phenotype and consideration of additional risk factors
in multifactorial diseases will probably disclose more signif-
icant genetic variations in development of knee OA.
Age is one of major risk factors for OA31. Most knee OA
studies have been carried out on persons aged 60 years
and older. Only a few authors have focused their studies
on younger patients32,33. We believe that highlighting of
knee OA related problems in middle-aged individuals is
one of most signiﬁcant advantages of our study.
In conclusion, in the present study we observed different
effects of rs3740199 SNP on knee OA associated suscep-
tibility and progression traits. First, this SNP was associated
with susceptibility to OA in PFJ in middle-aged male pa-
tients. Second, rs3740199 polymorphism appears to asso-
ciate progression of narrowing of the joint space, which is
the result of the deterioration of the cartilage tissue mainly
in TFJ in women. Regarding presence of osteophytes, the
risk was more related to occurrence of bone spurs on the
lateral patellar margins in PFJ. Based on these results,
we suppose that the effect of the ADAM12 gene on the
pathogenesis of knee OA is probably site-speciﬁc and acti-
vation of various pathogenetic mechanisms in OA seem to
be remarkably gender-dependent.Conﬂict of interest
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